[1] 周亚光,于 水,赵纪敏,等. A型肉毒毒素治疗雄激素性脱发的临床研究[J].中国美容医学,2021,(5):101-103.
　 ZHOU Ya-guang,YU Shui,ZHAO Ji-min,et al. A Clinical Study on the Treatment of Androgenic Alopecia with Botulinum Toxin A[J].Medical Aesthetics and Beauty,2021,(5):101-103.
点击复制

 A型肉毒毒素治疗雄激素性脱发的临床研究
()
分享到：

《中国美容医学》[ISSN:1008-6445/CN:61-1347/R]

卷:
期数:
2021年5期
页码:
101-103
栏目:
出版日期:
2021-05-10

文章信息/Info

Title:
 A Clinical Study on the Treatment of Androgenic Alopecia with Botulinum Toxin A
文章编号:
1008-6455（2021）05-0101-03
作者:
 周亚光; 于 水; 赵纪敏; 赵梓纲
Author(s):
 ZHOU Ya-guang;  YU Shui;  ZHAO Ji-min;  ZHAO Zi-gang
关键词:
 [关键词]A型肉毒毒素; 非那雄胺; 雄激素性脱发; 双氢睾酮; 毛囊微小化
Keywords:
 Key words: Botulinum toxin A;  finasteride;  androgenetic alopecia;  dihydrotestosterone;  miniaturization of hair follicle
分类号:
R758.71
文献标志码:
A
摘要:
[摘要]目的：探究A型肉毒毒素治疗雄激素性脱发（Androgenic alopecia,AGA）的有效性及安全性。方法：将42例男性AGA
患者随机分为A型肉毒毒素注射+非那雄胺口服组（注射+口服组）和A型肉毒毒素注射组（注射组），两组每3个月进行1次注
射治疗，共2次。注射+口服组同时口服非那雄胺片，1毫克/次，1次/天。治疗期间定期记录头发变化及不良事件的发生。结
果：两组患者经治疗后均有明显疗效。注射+口服组每次治疗后较上次治疗前头发数量均有明显增加；注射组患者治疗6个月
后头发数量多于治疗前。两组每次治疗后头发数量进行比较，差异无明显统计学意义。两组均未出现明显副作用及并发症。
结论：A型肉毒毒素治疗雄激素性脱发安全、有效，联合口服非那雄胺疗效更佳，可临床推广应用。

Abstract:
Abstract:Objective To investigate the efficacy and safety of botulinum toxin type A (BTA) in patients with androgenic
alopecia (AGA). Methods 42 male patients with AGA were randomly divided into two groups: botulinum toxin A
injection+oral finasteride group (injection+oral group) and botulinum toxin A injection group (injection group). All patients
received the treatment for 6 months and were followed up every 3 months, 2 times in total during and The injection + oral group
was given finasteride tablets, 1mg each time, once a day. After completion of the treatment. Hair changes and adverse events
were recorded regularly during the treatment. Results Hair counts in both groups were significantly higher as compared with
those before treatment.Hair counts in the injection+oral group after each treatment was significantly increased compared with
that before the last treatment and those in the injection group after 6 months of treatment was more than that before treatment.
There was no significant difference between the two groups after treatment and no side effects and complications in both groups
were observed. Conclusion Botulinum toxin A is a safe and effective therapeutic strategy for the treatment of AGA.The
combination of oral finasteride was more effective.

相似文献/References:

[1] 羊乃康,孙 琦. A型肉毒毒素与曲安奈德治疗瘢痕疙瘩的疗效和安全性比较[J].中国美容医学,2020,(5):66.
　 YANG Nai-kang,SUN Qi. Comparison of Effi cacy and Safety Between Botulinum Toxin Type A andTriamcinolone Acetonide in the Treatment of Keloid[J].Medical Aesthetics and Beauty,2020,(5):66.
[2] 张珍珍,张向东,赵 琳,等. A型肉毒毒素影响透明质酸钠凝胶酶解反应的实验研究[J].中国美容医学,2020,(5):110.
　 ZHANG Zhen-zhen,ZHANG Xiang-dong,ZHAO Lin,et al. Experimental Study on the Inhibition of Hyaluronic Acid Gel Hydrolysis by Botulinum Toxin Type A[J].Medical Aesthetics and Beauty,2020,(5):110.
[3] 孙志成,闫国良,肖 斐,等. “五定原则”指导下行A型肉毒毒素注射面部除皱疗效探讨[J].中国美容医学,2021,(2):79.
　 SUN Zhi-cheng,YAN Guo-liang,XIAO Fei,et al. Efficacy of Botulinum Toxin Type A Injection in Facial Rhytidectomy Guided by “FiveLimit Principles”[J].Medical Aesthetics and Beauty,2021,(5):79.
[4] 周亚光 张美楠 赵纪敏 综述,赵梓纲 审校. A型肉毒毒素治疗面部潮红的临床应用及研究进展[J].中国美容医学,2021,(2):183.
　 ZHOU Ya-guang,ZHANG Mei-nan,ZHAO Ji-min,et al. Clinical Application and Research Progress of Botulinum Toxin A in the Treatment ofFacial Flushing[J].Medical Aesthetics and Beauty,2021,(5):183.

更新日期/Last Update: 2021-06-08